R&D Tax Incentive: boosting biotech innovation in Australia
Australia's bet is to keep its biotech landscape innovative throught R&D tax incentives. Delve into their strategy and its results.| Labiotech.eu
Australia's bet is to keep its biotech landscape innovative throught R&D tax incentives. Delve into their strategy and its results.| Labiotech.eu
The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January 2025.| Labiotech.eu
